The article Breaking News: Silo Pharma Uplists to the NASDAQ was originally published on Microdose. In surprising industry news, Silo Pharma has uplisted...
The company is also spending big bucks for its media outreach. The post Oregon’s Silo Wellness Buys Dyscovry Science To Aid Psychedelic Retreats appeared...
Existing treatments for fibromyalgia have limited efficacy. The post Tryp Looks at Patent for Psilocybin to Treat Fibromyalgia appeared first on Green...
Numinus ($NUMI) CEO, Payton Nyquvest, joins the Investor Hotseat to field hot questions from host, Dustin Robinson of Iter Investments. Numinus empowers...
The article News You Might Have Missed: Sep 26th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Mydecine Innovations Group Inc. (NEO: MYCO | OTC: MYCOF | FSE: 0NFA) a biotechnology company engineering the next wave of innovative medications and treatment...
Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) is pleased to announce it has entered into a Letter of Intent with Medelys Laboratories...
In this edition of Weekly Extractions, host Adam Tubero provides an update on a story we’ve been following closely over the past several weeks. For starters,...
Researchers are comparing near-death experiences (NDE) to psychedelics-imagined “death” experiences to learn more about both. The post Psychedelics...
The article HAVN Life Shutting Down? was originally published on Microdose. Unfortunate news for investors in HAVN Life Sciences as it seems the company...